TITLE:
CAFE Comparison of Atypicals in First Episode of Psychosis

CONDITION:
Schizophrenia

INTERVENTION:
Olanzapine, risperidone

SUMMARY:

      The purpose of this study is to compare the effectiveness, tolerability, and efficacy of the
      currently available atypical antipsychotic drugs olanzapine (2.5-20 mg/day), quetiapine
      (100-800 mg/day) and risperidone (0.5-4 mg/day) in patients with schizophrenia,
      schizophreniform disorder, or schizoaffective disorder who are experiencing their first
      psychotic episode.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 16 Years to 40 Years
Criteria:

        Inclusion Criteria:

          -  Patients must meet criteria for schizophreniform disorder, schizophrenia, or
             schizoaffective disorder with psychotic symptoms lasting 1-60 months

          -  Psychotic symptoms must have persisted at least one month, and not more thn 5 years
             (60 months)

          -  Patients must have no previous history of drug treatment (greater than a total of 16
             weeks) with antipsychotics

        Exclusion Criteria:

          -  Patients with history of psychotic disorder with recovery period of at least 3 months

          -  Female patients who are pregnant or nursing

          -  Patients with a known history of mental retardation
      
